MRNA distribution of the thalidomide binding protein cereblon in adult mouse brain

Neuroscience Research

Volumn 69, Issue 4, 2011, Pages 343-347

  Aizawa, Miho ^a   Abe, Yuichi ^a   Ito, Takumi ^b   Handa, Hiroshi ^b   Nawa, Hiroyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Autism; Crbn; Hypnotic; Noradrenalin; Serotonin; Thalidomide

Indexed keywords

DRUG BINDING PROTEIN; MESSENGER RNA; THALIDOMIDE;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG DISTRIBUTION; EMBRYO; HUMAN; LOCUS CERULEUS; MALE; MOUSE; NONHUMAN; NORADRENERGIC NERVE; OLIGODENDROGLIA; PRIORITY JOURNAL; RAPHE NUCLEUS; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURONS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TERATOGENS; THALIDOMIDE;

EID: 79951956830     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.12.019     Document Type: Article

References (22)

1. Abe Y., Namba H., Zheng Y., Nawa H. In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 2009, 161:95-110.
2. Anderson G.M., Freedman D.X., Cohen D.J., Volkmar F.R., Hoder E.L., McPhedran P., Minderaa R.B., Hansen C.R., Young J.G. Whole blood serotonin in autistic and normal subjects. J. Child Psychol. Psychiatry 1987, 28:885-900.
3. Anderson G.M., Horne W.C., Chatterjee D., Cohen D.J. The hyperserotonemia of autism. Ann. N. Y. Acad. Sci. 1990, 600:331-340.
4. Angers S., Li T., Yi X., MacCoss M.J., Moon R.T., Zheng N. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 2006, 443:590-593.
5. Chugani D.C. Role of altered brain serotonin mechanisms in autism. Mol. Psychiatry 2002, 7:S16-S17.
6. Chugani D.C., Chugani H.T. PET: mapping of serotonin synthesis. Adv. Neurol. 2000, 83:165-171.
7. Chugani D.C., Muzik O., Rothermel R., Behen M., Chakraborty P., Mangner T., da Silva E.A., Chugani H.T. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann. Neurol. 1997, 42:666-669.
8. Eriksson T., Bjorkman S., Hoglund P. Clinical pharmacology of thalidomide. Eur. J. Clin. Pharmacol. 2001, 57:365-376.
9. Higgins J.J., Pucilowska J., Lombardi R.Q., Rooney J.P. A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 2004, 63:1927-1931.
10. Higgins J.J., Hao J., Kosofsky B.E., Rajadhyaksha A.M. Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation. Neurogenetics 2008, 9:219-223.
11. Higgins J.J., Tal A.L., Sun X., Hauck S.C., Hao J., Kosofosky B.E., Rajadhyaksha A.M. Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence. J. Neurogenet. 2010, 24:18-26.
12. Hohberger B., Enz R. Cereblon is expressed in the retina and binds to voltage-gated chloride channels. FEBS Lett. 2009, 583:633-637.
13. Ito T., Ando H., Suzuki T., Ogura T., Hotta K., Imamura Y., Yamaguchi Y., Handa H. Identification of a primary target of thalidomide teratogenicity. Science 2010, 327:1345-1350.
14. Jo S., Lee K.H., Song S., Jung Y.K., Park C.S. Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain. J. Neurochem. 2005, 94:1212-1224.
15. Miyazaki K., Narita N., Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int. J. Dev. Neurosci. 2005, 23:287-297.
16. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., Okado N. Increased monoamine concentration in the brain and the blood of fetal thalidomide and valproic acid exposed rat; putative animal models for autism. Pediatric Res. 2002, 52:576-579.
17. Narita M., Oyabu A., Imura Y., Kamada N., Yokoyama T., Tano K., Uchida A., Narita N. Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat. Neurosci. Res. 2010, 66:2-6.
18. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2004, Academic Press, San Diego, CA, USA.
19. Rozen S., Skaletskey H. Primer3-web 0.3.0 2000, http://primer3.sourceforge.net/.
20. Stromland K., Nordin V., Miller M., Akerstrom B., Gillberg C. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 1994, 36:351-356.
21. Watakabe A., Ichinohe N., Ohsawa S., Hashikawa T., Komatsu Y., Rockland K.S., Yamamori T. Comparative analysis of layer-specific genes in mammalian neocortex. Cereb. Cortex 2007, 17:1918-1933.
22. Xin W., Xiaohua N., Peilin C., Xin C., Yaqiong S., Qihan W. Primary function analysis of human mental retardation related gene CRBN. Mol. Biol. Rep. 2008, 35:251-256.